REICIN ALISE (PRES., GLOBAL CLINICAL DEV.) exercised options at CELGENE CORP /DE/
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/4/2019ACC: 0001415889-19-001258
Officer· PRES., GLOBAL CLINICAL DEV.
Since Nov 2018
-4.72K
Net shares
Net seller
$512.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
11.90K acquired · 16.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.90K
Price / share
—
Trade value
—
% of position
New position
11/1/2019
0.00→11.90K
Common Stock
Direct
Shares
−4.72K
Price / share
$108.53
Trade value
$512.48K
% of position
39.7%
11/1/2019
11.90K→7.18K
Total
Net shares
+7.18K
Net value
-$512.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2019 | M · Option Exercise | +11.90K | — | — | New position | 0.00 | 11.90K |
| Common Stock Direct | 11/1/2019 | F · Tax Withholding | −4.72K | $108.53 | $512.48K | 39.7% | 11.90K | 7.18K |
| Total | +7.18K | -$512.48K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
11.90K shares
Shares
−11.90K
Strike price
Held after
23.81K
Exercisable
—
11/1/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock11.90K shares | 11/1/2019 | M · Option Exercise | −11.90K | — | 23.81K |